- Home
- TRML vs ADV Comparison
TRML vs ADV Comparison
Compare TRML & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- ADV
- Stock Information
- Founded
- TRML 2021
- ADV 1987
- Country
- TRML United States
- ADV United States
- Employees
- TRML N/A
- ADV N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- ADV Business Services
- Sector
- TRML Health Care
- ADV Consumer Discretionary
- Exchange
- TRML Nasdaq
- ADV Nasdaq
- Market Cap
- TRML 598.9M
- ADV 586.7M
- IPO Year
- TRML N/A
- ADV N/A
- Fundamental
- Price
- TRML $47.65
- ADV $1.96
- Analyst Decision
- TRML Hold
- ADV Strong Buy
- Analyst Count
- TRML 12
- ADV 1
- Target Price
- TRML $47.04
- ADV $2.50
- AVG Volume (30 Days)
- TRML 1.6M
- ADV 660.2K
- Earning Date
- TRML 11-06-2025
- ADV 11-06-2025
- Dividend Yield
- TRML N/A
- ADV N/A
- EPS Growth
- TRML N/A
- ADV N/A
- EPS
- TRML N/A
- ADV N/A
- Revenue
- TRML N/A
- ADV $3,527,054,000.00
- Revenue This Year
- TRML N/A
- ADV N/A
- Revenue Next Year
- TRML N/A
- ADV N/A
- P/E Ratio
- TRML N/A
- ADV N/A
- Revenue Growth
- TRML N/A
- ADV N/A
- 52 Week Low
- TRML $11.56
- ADV $1.04
- 52 Week High
- TRML $47.70
- ADV $4.10
- Technical
- Relative Strength Index (RSI)
- TRML 94.40
- ADV 61.46
- Support Level
- TRML $22.31
- ADV $1.78
- Resistance Level
- TRML $47.69
- ADV $1.93
- Average True Range (ATR)
- TRML 1.15
- ADV 0.09
- MACD
- TRML 2.54
- ADV 0.00
- Stochastic Oscillator
- TRML 99.80
- ADV 75.34
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.